cilostazol has been researched along with Neointima in 5 studies
Neointima: The new and thickened layer of scar tissue that forms on a PROSTHESIS, or as a result of vessel injury especially following ANGIOPLASTY or stent placement.
| Excerpt | Relevance | Reference |
|---|---|---|
| "to evaluate whether systemic administration of cilostazol reduces neointimal hyperplasia in iliac arteries of pigs submitted to balloon catheter angioplasty." | 7.81 | Effect of cilostazol on neointimal hyperplasia in iliac arteries of pigs after transluminal angioplasty. ( Longhi, JA; Pereira, AH, 2015) |
| "Cilostazol-treated grafts had a thinner intima layer with less myocyte content compared with control grafts, amounting to an 82 percent decrease in total intima area compared with controls." | 5.40 | Topical cilostazol inhibits neointimal hyperplasia in a rat interposition vein graft model. ( Akelina, Y; Ascherman, JA; Malliaris, SD; Munabi, NCO, 2014) |
| "to evaluate whether systemic administration of cilostazol reduces neointimal hyperplasia in iliac arteries of pigs submitted to balloon catheter angioplasty." | 3.81 | Effect of cilostazol on neointimal hyperplasia in iliac arteries of pigs after transluminal angioplasty. ( Longhi, JA; Pereira, AH, 2015) |
| " Long-term administration of cilostazol is more effective in reducing neointimal formation at non-overlapping segments of BESs in a porcine coronary model." | 3.79 | The impact of triple anti-platelet therapy for endothelialization and inflammatory response at overlapping bioabsorbable polymer coated drug-eluting stents in a porcine coronary model. ( Ahn, Y; Cho, JG; Hong, YJ; Jeong, MH; Kang, JC; Kim, JH; Kim, JM; Kim, KH; Lee, KH; Lim, KS; Park, DS; Park, HW; Park, JC; Park, KH; Sim, DS; Yoon, HJ; Yoon, NS, 2013) |
| "Cilostazol, a potent type 3 phosphodiesterase inhibitor, has recently been found to reduce neointimal formation by inhibiting vascular smooth muscle cell (VSMC) proliferation." | 3.77 | Cilostazol promotes vascular smooth muscles cell differentiation through the cAMP response element-binding protein-dependent pathway. ( Chen, WJ; Chen, YH; Lin, KH; Ting, CH; Yeh, YH, 2011) |
| "Cilostazol-treated grafts had a thinner intima layer with less myocyte content compared with control grafts, amounting to an 82 percent decrease in total intima area compared with controls." | 1.40 | Topical cilostazol inhibits neointimal hyperplasia in a rat interposition vein graft model. ( Akelina, Y; Ascherman, JA; Malliaris, SD; Munabi, NCO, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malliaris, SD | 1 |
| Munabi, NCO | 1 |
| Akelina, Y | 1 |
| Ascherman, JA | 1 |
| Longhi, JA | 1 |
| Pereira, AH | 1 |
| Zuliani Mauro, MF | 1 |
| Mangione, JA | 1 |
| Costa, JR | 1 |
| Costa, R | 1 |
| Piva E Mattos, LA | 1 |
| Staico, R | 1 |
| Feres, F | 1 |
| Siqueira, D | 1 |
| Sousa, A | 1 |
| Abizaid, A | 1 |
| Chen, WJ | 1 |
| Chen, YH | 1 |
| Lin, KH | 1 |
| Ting, CH | 1 |
| Yeh, YH | 1 |
| Park, KH | 1 |
| Jeong, MH | 1 |
| Kim, JM | 1 |
| Park, DS | 1 |
| Kim, JH | 2 |
| Lim, KS | 1 |
| Lee, KH | 1 |
| Sim, DS | 1 |
| Yoon, HJ | 1 |
| Yoon, NS | 1 |
| Kim, KH | 1 |
| Park, HW | 1 |
| Hong, YJ | 1 |
| Ahn, Y | 1 |
| Cho, JG | 1 |
| Park, JC | 1 |
| Kang, JC | 1 |
1 trial available for cilostazol and Neointima
| Article | Year |
|---|---|
Randomized Angiographic and Intravascular Ultrasound Comparison of Dual-Antiplatelet Therapy vs Triple-Antiplatelet Therapy to Reduce Neointimal Tissue Proliferation in Diabetic Patients.
Topics: Aspirin; Cilostazol; Clopidogrel; Comorbidity; Coronary Angiography; Coronary Artery Disease; Corona | 2017 |
4 other studies available for cilostazol and Neointima
| Article | Year |
|---|---|
Topical cilostazol inhibits neointimal hyperplasia in a rat interposition vein graft model.
Topics: Administration, Topical; Animals; Cilostazol; Graft Occlusion, Vascular; Hyperplasia; Neointima; Pla | 2014 |
Effect of cilostazol on neointimal hyperplasia in iliac arteries of pigs after transluminal angioplasty.
Topics: Angioplasty; Animals; Cilostazol; Hyperplasia; Iliac Artery; Neointima; Phosphodiesterase 3 Inhibito | 2015 |
Cilostazol promotes vascular smooth muscles cell differentiation through the cAMP response element-binding protein-dependent pathway.
Topics: Animals; Carotid Arteries; Cell Differentiation; Cells, Cultured; Cilostazol; Contractile Proteins; | 2011 |
The impact of triple anti-platelet therapy for endothelialization and inflammatory response at overlapping bioabsorbable polymer coated drug-eluting stents in a porcine coronary model.
Topics: Absorbable Implants; Animals; Aspirin; Cilostazol; Clopidogrel; Coated Materials, Biocompatible; Cor | 2013 |